計量生物学
Online ISSN : 2185-6494
Print ISSN : 0918-4430
総説
代替エンドポイントの評価のための統計的基準とその適用事例
田中 司朗大庭 幸治吉村 健一手良向 聡
著者情報
ジャーナル フリー

2010 年 31 巻 1 号 p. 23-48

詳細
抄録

Surrogate endpoints, which represent a compromise in the conflict between measurability and clinical relevance of endpoints, have considerable advantage in rapid drug approvals compared to true endpoints in confirmatory clinical trials dealing with life-threatening diseases, such as cancer or AIDS. However, past experiences have shown the risk of relying too heavily on surrogate endpoints. In this paper, we review statistical criteria for evaluating surrogate endpoints and the past examples properly evaluated the surrogacy, taking into consideration relevant clinical and statistical issues.

著者関連情報
© 2010 日本計量生物学会
前の記事
feedback
Top